Sign inGet started

NUVB

Nuvation Bio Inc.CIK 1811063 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$1.42M
2 trades · 1 insiders
Net · 90d
$-1.42M
Insiders on file
31

AI insights for NUVB PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for NUVB
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

$1.42M2026-08-19 buys — 2026-08-19 sales $1.42M08-19
■ Open-market buys (P)   ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

InsiderRoleTradesBoughtSoldLast trade
Hattersley GaryChief Scientific Officer23$0$4.59M2026-08-19
Sauvage PhilippeChief Financial Officer12$13.2K$286.5K2026-07-15
Markel StacySVP, Human Resources14$17.1K$753.8K2026-06-23
Wentworth KerryChief Regulatory Officer20$89.7K$1.47M2026-06-23
Mashal RobertDirector10$505.3K$02026-06-09
Bazemore Robert BDirector10$49.9K$02026-05-21
Cui XiangminDirector22$2.32M$02026-05-21
VERNON W ANTHONYDirector11$0$02026-05-21
BLICKENSTAFF KIM DDirector10$499.3K$02026-05-21
FALBERG KATHRYN EDirector12$483.1K$02026-05-21
Liu DongfangChief Medical Officer31$0$1.92M2026-04-17
Sjogren ColleenChief Commercial Officer5$90.5K$02026-02-27
Makunje MosesSEE REMARKS4$0$02026-02-27
Hanley David C.Chief Technical Operations11$0$1.43M2026-02-27
Hung DavidPresident and CEO14$1.72M$02026-02-27
Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LTD.13$0$162.9K2024-11-11
WELCH DANIEL GDirector10$0$02024-05-24
EcoR1 Capital Fund Qualified, L.P.Director9$11.31M$02023-09-21
Fox Jennifer A.Chief Financial Officer5$0$02023-02-28
NODELMAN OLEGDirector, 10% Owner4$6.71M$02023-02-21
Omega Fund V GP Manager, Ltd.10% Owner8$0$27.04M2022-04-05
Omega Fund IV GP, L.P.10% Owner1$0$5.04M2021-12-15
Omega Fund V, L.P.10% Owner1$0$13.72M2021-12-07
EcoR1 Capital, LLCOther18$3.50M$2.07M2021-11-24
Omega Fund V GP, L.P.10% Owner1$0$18.50M2021-11-03
Yurasov SergeyChief Medical Officer2$0$02021-02-10
Templeman ThomasSVP, Pharmaceutical Ops2$0$02021-02-10
COOPER GRAHAM KDirector2$0$02021-02-10
Sharp ShaliniDirector3$0$02021-02-10
Hasnain FaheemDirector3$0$02021-02-10
BRADBURY DANIELDirector2$0$02021-02-10

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Hattersley GaryCHIEF SCIENTIFIC OFFICER M Exercise deriv2026-08-192026-08-21100,000— $0400,000SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER S Sale2026-08-192026-08-21100,000$7.09 $709.0K0SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER M Exercise2026-08-192026-08-21100,000$1.87 $187.0K100,000SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER M Exercise deriv2026-08-192026-08-21100,000— $0400,000SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER S Sale2026-08-192026-08-21100,000$7.09 $709.2K0SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER M Exercise2026-08-192026-08-21100,000$1.87 $187.0K100,000SEC↗
Sauvage PhilippeChief Financial Officer M Exercise deriv2026-07-152026-07-171— $0499,999SEC↗
Sauvage PhilippeChief Financial Officer M Exercise deriv2026-07-152026-07-1739,999— $0662,333SEC↗
Sauvage PhilippeChief Financial Officer M Exercise2026-07-152026-07-1739,999$2.17 $86.8K54,130SEC↗
Sauvage PhilippeChief Financial Officer M Exercise2026-07-152026-07-171$1.97 $254,131SEC↗
Sauvage PhilippeChief Financial Officer M Exercise deriv2026-06-232026-06-2447,668— $0702,332SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER M Exercise deriv2026-06-232026-06-2463,000— $0152,250SEC↗
Markel StacyCHIEF PEOPLE OFFICER M Exercise deriv2026-06-232026-06-2434,620— $0220,190SEC↗
Markel StacyCHIEF PEOPLE OFFICER M Exercise deriv2026-06-232026-06-2490,380— $0409,620SEC↗
Sauvage PhilippeChief Financial Officer S Sale2026-06-232026-06-2447,668$6.01 $286.5K12,673SEC↗
Sauvage PhilippeChief Financial Officer M Exercise2026-06-232026-06-2447,668$2.17 $103.4K60,341SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER M Exercise2026-06-232026-06-2463,000$2.93 $184.6K116,000SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER S Sale2026-06-232026-06-2463,000$6.02 $379.3K53,000SEC↗
Markel StacyCHIEF PEOPLE OFFICER M Exercise2026-06-232026-06-2434,620$1.74 $60.2K157,591SEC↗
Markel StacyCHIEF PEOPLE OFFICER S Sale2026-06-232026-06-24125,000$6.03 $753.8K32,591SEC↗
Markel StacyCHIEF PEOPLE OFFICER M Exercise2026-06-232026-06-2490,380$1.87 $169.0K122,971SEC↗
Mashal RobertDirector P Buy2026-06-092026-06-1125,000$4.73 $118.3K225,000SEC↗
Cui XiangminDirector A Award deriv2026-05-212026-05-26123,397— $0123,397SEC↗
Bazemore Robert BDirector A Award deriv2026-05-212026-05-26123,397— $0123,397SEC↗
BLICKENSTAFF KIM DDirector A Award deriv2026-05-212026-05-26123,397— $0123,397SEC↗
FALBERG KATHRYN EDirector A Award deriv2026-05-212026-05-26123,397— $0123,397SEC↗
Mashal RobertDirector A Award deriv2026-05-212026-05-26123,397— $0123,397SEC↗
VERNON W ANTHONYDirector A Award deriv2026-05-212026-05-26123,397— $0123,397SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise deriv2026-04-172026-04-2150,000— $0430,000SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER M Exercise deriv2026-04-172026-04-2136,750— $0215,250SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise2026-04-172026-04-2150,000$1.94 $97.0K68,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER S Sale2026-04-172026-04-2150,000$5.02 $251.0K18,000SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER S Sale2026-04-172026-04-2136,750$5.01 $184.1K53,000SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER M Exercise2026-04-172026-04-2136,750$2.93 $107.7K89,750SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER M Exercise deriv2026-04-062026-04-08100,000— $0300,000SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER M Exercise deriv2026-04-062026-04-08100,000— $0400,000SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER M Exercise2026-04-062026-04-08100,000$1.87 $187.0K153,000SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER M Exercise2026-04-062026-04-08100,000$1.94 $194.0K253,000SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER S Sale2026-04-062026-04-08200,000$4.52 $904.0K53,000SEC↗
Cui XiangminDirector A Award deriv2026-02-272026-05-2676,923— $076,923SEC↗
Hung DavidPRESIDENT AND CEO A Award deriv2026-02-272026-03-031,995,012— $01,995,012SEC↗
Hanley David C.CHIEF TECHNICAL OPERATIONS A Award deriv2026-02-272026-03-03748,130— $0748,130SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER A Award deriv2026-02-272026-03-03748,130— $0748,130SEC↗
Cui XiangminDirector A Award deriv2026-02-272026-03-0374,813— $074,813SEC↗
Markel StacyCHIEF PEOPLE OFFICER A Award deriv2026-02-272026-03-03748,130— $0748,130SEC↗
Sauvage PhilippeChief Financial Officer A Award deriv2026-02-272026-03-03748,130— $0748,130SEC↗
Sjogren ColleenChief Commercial Officer A Award deriv2026-02-272026-03-03748,130— $0748,130SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER A Award deriv2026-02-272026-03-03748,130— $0748,130SEC↗
Makunje MosesSEE REMARKS A Award deriv2026-02-272026-03-03224,439— $0224,439SEC↗
Liu DongfangCHIEF MEDICAL OFFICER A Award deriv2026-02-272026-03-03748,130— $0748,130SEC↗
Makunje MosesSEE REMARKS A Award2026-02-272026-03-0350,761— $068,137SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise deriv2025-12-012025-12-03150,000— $0165,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER S Sale2025-12-012025-12-03150,000$7.82 $1.17M18,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise2025-12-012025-12-03150,000$2.93 $439.5K168,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise deriv2025-11-262025-11-2610,000— $0470,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise2025-11-262025-11-2610,000$3.61 $36.1K28,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER S Sale2025-11-262025-11-2610,000$8.00 $80.0K18,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise deriv2025-11-252025-11-2610,000— $0480,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise2025-11-252025-11-2610,000$3.61 $36.1K28,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER S Sale2025-11-252025-11-2610,000$7.50 $75.0K18,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise deriv2025-11-202025-11-2420,000— $0450,000SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER M Exercise deriv2025-11-202025-11-24300,000— $0200,000SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER M Exercise deriv2025-11-202025-11-2469,051— $0229,884SEC↗
Liu DongfangCHIEF MEDICAL OFFICER S Sale2025-11-202025-11-2420,000$7.00 $140.0K18,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise2025-11-202025-11-2420,000$1.87 $37.4K38,000SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER S Sale2025-11-202025-11-24300,000$7.23 $2.17M0SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER M Exercise2025-11-202025-11-24300,000$1.94 $582.0K300,000SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER S Sale2025-11-202025-11-2469,051$7.23 $499.2K0SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER M Exercise2025-11-202025-11-2469,051$1.74 $120.1K69,051SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise deriv2025-11-192025-11-1915,000— $0470,000SEC↗
Hanley David C.CHIEF TECHNICAL OPERATIONS M Exercise deriv2025-11-192025-11-21200,000— $0300,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER S Sale2025-11-192025-11-1915,000$5.10 $76.5K18,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise2025-11-192025-11-1915,000$1.87 $28.1K30,000SEC↗
Hanley David C.CHIEF TECHNICAL OPERATIONS S Sale2025-11-192025-11-21200,000$7.14 $1.43M24,000SEC↗
Hanley David C.CHIEF TECHNICAL OPERATIONS M Exercise2025-11-192025-11-21200,000$1.87 $374.0K224,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise deriv2025-11-172025-11-1915,000— $0485,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER S Sale2025-11-172025-11-1915,000$4.77 $71.5K15,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise2025-11-172025-11-1915,000$1.87 $28.1K30,000SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER M Exercise deriv2025-10-272025-10-29100,000— $0298,935SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER M Exercise2025-10-272025-10-29100,000$1.74 $174.0K100,000SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER S Sale2025-10-272025-10-29100,000$5.02 $502.0K0SEC↗
Mashal RobertDirector G Gift deriv2025-08-112025-08-13350,001— $0391,178SEC↗
Mashal RobertDirector G Gift deriv2025-08-112025-08-13350,001— $0350,001SEC↗
Markel StacyCHIEF PEOPLE OFFICER P Buy2025-06-182025-06-1810,000$1.71 $17.1K29,591SEC↗
Sauvage PhilippeChief Financial Officer P Buy2025-06-172025-06-184,000$1.79 $7.2K9,902SEC↗
Hung DavidPRESIDENT AND CEO P Buy2025-06-162025-06-18500,000$1.79 $895.0K59,281,054SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER P Buy2025-06-162025-06-1826,000$1.79 $46.5K26,000SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER P Buy2025-06-162025-06-1824,000$1.80 $43.2K50,000SEC↗
Sjogren ColleenChief Commercial Officer P Buy2025-06-162025-06-1850,000$1.81 $90.5K81,000SEC↗
Sauvage PhilippeChief Financial Officer P Buy2025-06-162025-06-183,300$1.84 $6.1K5,902SEC↗
Bazemore Robert BDirector A Award deriv2025-05-212025-05-23292,983— $0292,983SEC↗
BLICKENSTAFF KIM DDirector A Award deriv2025-05-212025-05-23292,983— $0292,983SEC↗
FALBERG KATHRYN EDirector A Award deriv2025-05-212025-05-23292,983— $0292,983SEC↗
Mashal RobertDirector A Award deriv2025-05-212025-05-23292,983— $0292,983SEC↗
VERNON W ANTHONYDirector A Award deriv2025-05-212025-05-23292,983— $0292,983SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise deriv2025-05-022025-05-0620,000$1.94 $38.8K480,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER M Exercise2025-05-022025-05-0620,000$1.94 $38.8K32,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER S Sale2025-05-022025-05-0620,000$2.50 $50.0K12,000SEC↗
Hung DavidPRESIDENT AND CEO P Buy2025-04-072025-04-08300,000$1.63 $489.0K58,781,054SEC↗
Hung DavidPRESIDENT AND CEO P Buy2025-04-042025-04-08200,000$1.66 $332.0K58,481,054SEC↗
Mashal RobertDirector P Buy2025-04-012025-04-031,100$1.67 $1.8K101,100SEC↗
Mashal RobertDirector P Buy2025-04-012025-04-0398,900$1.67 $165.2K200,000SEC↗
Hanley David C.CHIEF TECHNICAL OPERATIONS A Award deriv2025-02-282025-03-04500,000— $0500,000SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER A Award deriv2025-02-282025-03-04500,000— $0500,000SEC↗
Hung DavidPRESIDENT AND CEO A Award deriv2025-02-282025-03-042,000,000— $02,000,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER A Award deriv2025-02-282025-03-04500,000— $0500,000SEC↗
Makunje MosesSEE REMARKS A Award deriv2025-02-282025-03-04250,000— $0250,000SEC↗
Markel StacyCHIEF PEOPLE OFFICER A Award deriv2025-02-282025-03-04500,000— $0500,000SEC↗
Sauvage PhilippeChief Financial Officer A Award deriv2025-02-282025-03-04500,000— $0500,000SEC↗
Sjogren ColleenChief Commercial Officer A Award deriv2025-02-282025-03-04500,000— $0500,000SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER A Award deriv2025-02-282025-03-04500,000— $0500,000SEC↗
Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LT S Sale2024-11-112024-11-1356,361$2.89 $162.9K3,866,228SEC↗
Mashal RobertDirector P Buy2024-10-082024-10-1099,981$2.20 $220.0K100,000SEC↗
Mashal RobertDirector P Buy2024-10-082024-10-1019$2.20 $4219SEC↗
Sauvage PhilippeChief Financial Officer A Award deriv2024-10-072024-10-09750,000— $0750,000SEC↗
Cui XiangminDirector C Conversion deriv2024-09-042024-09-0551,579— $00SEC↗
Cui XiangminDirector C Conversion deriv2024-09-042024-09-05128,792— $00SEC↗
Cui XiangminDirector C Conversion deriv2024-09-042024-09-059,671— $00SEC↗
Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LT C Conversion deriv2024-09-042024-09-0525,436— $00SEC↗
Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LT C Conversion deriv2024-09-042024-09-0516,957— $00SEC↗
Cui XiangminDirector C Conversion2024-09-042024-09-055,157,900— $07,611,031SEC↗
Cui XiangminDirector C Conversion2024-09-042024-09-05967,100— $01,281,206SEC↗
Cui XiangminDirector C Conversion2024-09-042024-09-0512,879,200— $017,062,202SEC↗
Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LT C Conversion2024-09-042024-09-052,543,600— $03,922,589SEC↗
Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LT C Conversion2024-09-042024-09-051,695,700— $02,246,458SEC↗
Cui XiangminDirector A Award deriv2024-09-032024-09-0551,579— $051,579SEC↗
Cui XiangminDirector A Award deriv2024-09-032024-09-059,671— $09,671SEC↗
Cui XiangminDirector A Award deriv2024-09-032024-09-05128,792— $0128,792SEC↗
Cui XiangminDirector A Award deriv2024-09-032024-09-05437,834— $0437,834SEC↗
Cui XiangminDirector A Award deriv2024-09-032024-09-05175,346— $0175,346SEC↗
Cui XiangminDirector A Award deriv2024-09-032024-09-0532,877— $032,877SEC↗
Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LT A Award deriv2024-09-032024-09-0516,957— $016,957SEC↗
Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LT A Award deriv2024-09-032024-09-0525,436— $025,436SEC↗
Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LT A Award deriv2024-09-032024-09-0586,471— $086,471SEC↗
Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LT A Award deriv2024-09-032024-09-0557,647— $057,647SEC↗
Bazemore Robert BDirector A Award deriv2024-09-032024-09-05200,801— $0200,801SEC↗
BLICKENSTAFF KIM DDirector A Award deriv2024-09-032024-09-05200,801— $0200,801SEC↗
FALBERG KATHRYN EDirector A Award deriv2024-09-032024-09-05200,801— $0200,801SEC↗
VERNON W ANTHONYDirector A Award deriv2024-09-032024-09-05200,801— $0200,801SEC↗
Cui XiangminDirector P Buy2024-06-252024-06-26277,895$2.97 $825.3K2,453,131SEC↗
Cui XiangminDirector P Buy2024-06-242024-06-25336,874$2.98 $1.00M2,175,236SEC↗
Cui XiangminDirector P Buy2024-06-212024-06-2575,411$3.00 $226.2K1,838,362SEC↗
Cui XiangminDirector P Buy2024-06-202024-06-2587,715$2.99 $262.3K1,762,951SEC↗
BLICKENSTAFF KIM DDirector P Buy2024-06-112024-06-13172,189$2.90 $499.3K172,189SEC↗
WELCH DANIEL GDirector M Exercise deriv2024-05-242024-05-29293,203— $019,547SEC↗
WELCH DANIEL GDirector M Exercise deriv2024-05-242024-05-29366,744— $00SEC↗
WELCH DANIEL GDirector M Exercise2024-05-242024-05-29366,744$1.64 $601.5K659,947SEC↗
WELCH DANIEL GDirector M Exercise2024-05-242024-05-29293,203$1.74 $510.2K293,203SEC↗
Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LT A Award deriv2024-04-092024-04-11486,669— $0486,669SEC↗
Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LT A Award deriv2024-04-092024-04-11388,299— $0388,299SEC↗
Sjogren ColleenChief Commercial Officer A Award deriv2024-04-092024-04-11250,000— $0250,000SEC↗
Sjogren ColleenChief Commercial Officer A Award deriv2024-04-092024-04-11500,000— $0500,000SEC↗
Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LT A Award2024-04-092024-04-11550,758— $0550,758SEC↗
Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LT A Award2024-04-092024-04-111,378,989— $01,378,989SEC↗
Cui XiangminDirector A Award2024-04-092024-04-114,183,002— $04,183,002SEC↗
Cui XiangminDirector A Award2024-04-092024-04-11314,106— $0314,106SEC↗
Cui XiangminDirector A Award2024-04-092024-04-111,675,236— $01,675,236SEC↗
Hung DavidPRESIDENT AND CEO A Award deriv2024-02-292024-03-042,000,000— $02,000,000SEC↗
Liu DongfangCHIEF MEDICAL OFFICER A Award deriv2024-02-292024-03-04500,000— $0500,000SEC↗
Hattersley GaryCHIEF SCIENTIFIC OFFICER A Award deriv2024-02-292024-03-04500,000— $0500,000SEC↗
Hanley David C.CHIEF TECHNICAL OPERATIONS A Award deriv2024-02-292024-03-04500,000— $0500,000SEC↗
Makunje MosesSEE REMARKS A Award deriv2024-02-292024-03-04250,000— $0250,000SEC↗
Markel StacyCHIEF PEOPLE OFFICER A Award deriv2024-02-292024-03-04500,000— $0500,000SEC↗
Wentworth KerryCHIEF REGULATORY OFFICER A Award deriv2024-02-292024-03-04500,000— $0500,000SEC↗
Mashal RobertDirector A Award deriv2024-01-082024-01-10741,179— $0741,179SEC↗
EcoR1 Capital Fund Qualified, Director P Buy2023-09-212023-09-2253,000$1.36 $72.1K12,674,775SEC↗
EcoR1 Capital Fund Qualified, Director P Buy2023-09-202023-09-22117,100$1.36 $159.3K12,621,775SEC↗
EcoR1 Capital Fund Qualified, Director P Buy2023-09-192023-09-225,143,000$1.26 $6.48M12,504,675SEC↗
Bazemore Robert BDirector A Award deriv2023-05-152023-05-17366,744— $0366,744SEC↗
BLICKENSTAFF KIM DDirector A Award deriv2023-05-152023-05-17366,744— $0366,744SEC↗
FALBERG KATHRYN EDirector A Award deriv2023-05-152023-05-17366,744— $0366,744SEC↗
VERNON W ANTHONYDirector A Award deriv2023-05-152023-05-17366,744— $0366,744SEC↗
WELCH DANIEL GDirector A Award deriv2023-05-152023-05-17366,744— $0366,744SEC↗
Hattersley GaryChief Scientific Officer A Award deriv2023-02-282023-03-02500,000— $0500,000SEC↗
Liu DongfangChief Medical Officer A Award deriv2023-02-282023-03-02500,000— $0500,000SEC↗
Wentworth KerryChief Regulatory Officer A Award deriv2023-02-282023-03-02400,000— $0400,000SEC↗
Fox Jennifer A.Chief Financial Officer A Award deriv2023-02-282023-03-02600,000— $0600,000SEC↗
Hanley David C.Chief Technical Operations A Award deriv2023-02-282023-03-02500,000— $0500,000SEC↗
Hung DavidPresident and CEO A Award deriv2023-02-282023-03-022,500,000— $02,500,000SEC↗
Markel StacyChief People Officer A Award deriv2023-02-282023-03-02500,000— $0500,000SEC↗
NODELMAN OLEGDirector P Buy2023-02-212023-09-2153,000$1.36 $72.1K12,674,775SEC↗
NODELMAN OLEGDirector P Buy2023-02-202023-09-21117,100$1.36 $159.3K12,621,775SEC↗
NODELMAN OLEGDirector P Buy2023-02-192023-09-215,143,000$1.26 $6.48M12,504,675SEC↗
FALBERG KATHRYN EDirector P Buy2022-12-052022-12-0543,000$1.95 $83.8K250,000SEC↗
FALBERG KATHRYN EDirector P Buy2022-12-022022-12-0547,000$1.98 $93.1K207,000SEC↗
FALBERG KATHRYN EDirector P Buy2022-12-012022-12-0584,959$1.97 $167.4K160,000SEC↗
FALBERG KATHRYN EDirector P Buy2022-11-302022-12-0575,041$1.85 $138.8K75,041SEC↗
Fox Jennifer A.Chief Financial Officer A Award deriv2022-08-292022-08-31480,000— $0480,000SEC↗
Hanley David C.Chief Technical Operations A Award deriv2022-08-292022-08-31450,000— $0450,000SEC↗
Hattersley GaryChief Scientific Officer A Award deriv2022-08-292022-08-31400,000— $0400,000SEC↗
Liu DongfangChief Medical Officer A Award deriv2022-08-292022-08-31315,000— $0315,000SEC↗
Markel StacyChief People Officer A Award deriv2022-08-292022-08-31450,000— $0450,000SEC↗
Wentworth KerryChief Regulatory Officer A Award deriv2022-08-292022-08-31252,000— $0252,000SEC↗
Liu DongfangChief Medical Officer A Award deriv2022-07-152022-07-19292,500— $0292,500SEC↗
Liu DongfangChief Medical Officer A Award deriv2022-07-152022-07-19490,000— $0490,000SEC↗
Wentworth KerryChief Regulatory Officer A Award deriv2022-05-232022-05-25247,500— $0247,500SEC↗
Wentworth KerryChief Regulatory Officer A Award deriv2022-05-232022-05-25330,000— $0330,000SEC↗
WELCH DANIEL GDirector A Award deriv2022-05-162022-05-18118,784— $0118,784SEC↗
VERNON W ANTHONYDirector A Award deriv2022-05-162022-05-18118,784— $0118,784SEC↗
FALBERG KATHRYN EDirector A Award deriv2022-05-162022-05-18118,784— $0118,784SEC↗
BLICKENSTAFF KIM DDirector A Award deriv2022-05-162022-05-18118,784— $0118,784SEC↗
Bazemore Robert BDirector A Award deriv2022-05-162022-05-18118,784— $0118,784SEC↗
Bazemore Robert BDirector A Award deriv2022-05-162022-06-28140,713— $0140,713SEC↗
BLICKENSTAFF KIM DDirector A Award deriv2022-05-162022-06-28140,713— $0140,713SEC↗
FALBERG KATHRYN EDirector A Award deriv2022-05-162022-06-28140,713— $0140,713SEC↗
VERNON W ANTHONYDirector A Award deriv2022-05-162022-06-28140,713— $0140,713SEC↗
WELCH DANIEL GDirector A Award deriv2022-05-162022-06-28140,713— $0140,713SEC↗
Omega Fund V GP Manager, Ltd.10% Owner S Sale2022-04-052022-04-072,500,000$5.60 $14.00M20,457,340SEC↗
Hung DavidPresident and CEO A Award deriv2022-02-282022-03-022,000,000— $02,000,000SEC↗
Fox Jennifer A.Chief Financial Officer A Award deriv2022-02-282022-03-02600,000— $0600,000SEC↗
Markel StacyChief People Officer A Award deriv2022-02-282022-03-02500,000— $0500,000SEC↗
Hanley David C.Chief Technical Operations A Award deriv2022-02-282022-03-02500,000— $0500,000SEC↗
Hattersley GaryChief Scientific Officer A Award deriv2022-02-282022-03-02500,000— $0500,000SEC↗
Omega Fund IV GP, L.P.10% Owner S Sale2021-12-152021-12-17500,000$10.07 $5.04M22,957,340SEC↗
Omega Fund V, L.P.10% Owner S Sale2021-12-072021-12-091,400,000$9.80 $13.72M23,457,340SEC↗
EcoR1 Capital, LLCOther P Buy2021-11-242021-11-3021,758$7.69 $167.3K1,169,241SEC↗
EcoR1 Capital, LLCOther P Buy2021-11-242021-11-30163,268$7.69 $1.26M7,361,675SEC↗
Omega Fund V GP Manager, Ltd.10% Owner S Sale2021-11-232021-11-2436$9.75 $35124,857,376SEC↗
Omega Fund V GP Manager, Ltd.10% Owner S Sale2021-11-222021-11-24295,000$9.76 $2.88M24,857,376SEC↗
Omega Fund V GP, L.P.10% Owner S Sale2021-11-032021-11-052,000,000$9.25 $18.50M25,152,376SEC↗
Bazemore Robert BDirector A Award deriv2021-10-292021-11-0245,229— $045,229SEC↗
FALBERG KATHRYN EDirector A Award deriv2021-10-292021-11-0245,229— $045,229SEC↗
VERNON W ANTHONYDirector A Award deriv2021-10-292021-11-0245,229— $045,229SEC↗
WELCH DANIEL GDirector A Award deriv2021-10-292021-11-0245,229— $045,229SEC↗
BLICKENSTAFF KIM DDirector A Award deriv2021-10-292021-11-0245,229— $045,229SEC↗
NODELMAN OLEGDirector, 10% Owner A Award deriv2021-10-292021-11-0245,229— $045,229SEC↗
Omega Fund V GP Manager, Ltd.10% Owner S Sale2021-10-292021-11-0145,000$9.27 $417.1K27,152,376SEC↗
Omega Fund V GP Manager, Ltd.10% Owner S Sale2021-10-282021-11-011,015,000$9.60 $9.74M27,197,376SEC↗
EcoR1 Capital, LLCOther P Buy2021-07-312021-11-3056,598$8.64 $489.0K7,198,407SEC↗
EcoR1 Capital, LLCOther S Sale2021-07-312021-11-3056,598$8.64 $489.0K1,147,483SEC↗
Hanley David C.Chief Technical Operations A Award deriv2021-06-012021-06-03250,000— $0250,000SEC↗
Hanley David C.Chief Technical Operations A Award deriv2021-06-012021-06-03187,500— $0187,500SEC↗
EcoR1 Capital Fund Qualified, 10% Owner P Buy2021-04-132021-04-1327,534$10.27 $282.8K6,990,265SEC↗
EcoR1 Capital Fund Qualified, 10% Owner P Buy2021-04-132021-04-133,966$10.27 $40.7K1,355,625SEC↗
EcoR1 Capital Fund Qualified, 10% Owner P Buy2021-04-122021-04-13116,255$9.49 $1.10M6,962,731SEC↗
EcoR1 Capital Fund Qualified, 10% Owner P Buy2021-04-122021-04-1316,745$9.49 $158.9K1,351,659SEC↗
EcoR1 Capital Fund Qualified, 10% Owner P Buy2021-04-092021-04-1337,770$10.03 $378.8K1,334,914SEC↗
EcoR1 Capital Fund Qualified, 10% Owner P Buy2021-04-092021-04-13262,230$10.03 $2.63M6,846,476SEC↗
EcoR1 Capital, LLCOther P Buy2021-03-312021-11-30151,544$10.45 $1.58M6,735,790SEC↗
EcoR1 Capital, LLCOther S Sale2021-03-312021-11-30151,544$10.45 $1.58M1,145,600SEC↗
Bazemore Robert BDirector P Buy2021-03-302021-04-015,000$9.98 $49.9K5,000SEC↗
Hung DavidPresident and CEO A Award deriv2021-03-092021-03-11224,760— $0224,760SEC↗
Hung DavidPresident and CEO A Award deriv2021-03-092021-03-11165,465— $0165,465SEC↗
Hung DavidPresident and CEO J Other2021-03-022023-03-02368,408— $058,281,054SEC↗
Hung DavidPresident and CEO A Award deriv2021-02-102021-02-121,000,000— $01,000,000SEC↗
Fox Jennifer A.Chief Financial Officer A Award deriv2021-02-102021-02-12558,506— $0558,506SEC↗
Fox Jennifer A.Chief Financial Officer A Award deriv2021-02-102021-02-12398,935— $0398,935SEC↗
Yurasov SergeyChief Medical Officer A Award deriv2021-02-102021-02-12398,935— $0398,935SEC↗
Yurasov SergeyChief Medical Officer A Award deriv2021-02-102021-02-12398,935— $0398,935SEC↗
Hattersley GaryChief Scientific Officer A Award deriv2021-02-102021-02-12398,935— $0398,935SEC↗
Hattersley GaryChief Scientific Officer A Award deriv2021-02-102021-02-12398,935— $0398,935SEC↗
Templeman ThomasSVP, Pharmaceutical Ops A Award deriv2021-02-102021-02-12398,935— $0398,935SEC↗
Templeman ThomasSVP, Pharmaceutical Ops A Award deriv2021-02-102021-02-12398,935— $0398,935SEC↗
Markel StacySVP, Human Resources A Award deriv2021-02-102021-02-12398,935— $0398,935SEC↗
Markel StacySVP, Human Resources A Award deriv2021-02-102021-02-12254,810— $0254,810SEC↗
WELCH DANIEL GDirector A Award deriv2021-02-102021-02-12312,750— $0312,750SEC↗
WELCH DANIEL GDirector A Award deriv2021-02-102021-02-1286,184— $086,184SEC↗
Bazemore Robert BDirector A Award deriv2021-02-102021-02-12187,658— $0187,658SEC↗
Bazemore Robert BDirector A Award deriv2021-02-102021-02-1251,703— $051,703SEC↗
BLICKENSTAFF KIM DDirector A Award deriv2021-02-102021-02-12187,658— $0187,658SEC↗
BLICKENSTAFF KIM DDirector A Award deriv2021-02-102021-02-1251,703— $051,703SEC↗
FALBERG KATHRYN EDirector A Award deriv2021-02-102021-02-12239,361— $0239,361SEC↗
VERNON W ANTHONYDirector A Award deriv2021-02-102021-02-1251,703— $051,703SEC↗
VERNON W ANTHONYDirector A Award deriv2021-02-102021-02-12187,658— $0187,658SEC↗
Omega Fund V GP Manager, Ltd.10% Owner C Conversion deriv2021-02-102021-02-128,130,097— $00SEC↗
EcoR1 Capital, LLC10% Owner C Conversion deriv2021-02-102021-02-122,775,000— $00SEC↗
EcoR1 Capital, LLC10% Owner A Award deriv2021-02-102021-02-12702,000— $0702,000SEC↗
EcoR1 Capital, LLC10% Owner A Award deriv2021-02-102021-02-12131,333— $0131,333SEC↗
EcoR1 Capital, LLC10% Owner A Award deriv2021-02-102021-02-12130,000— $0130,000SEC↗
COOPER GRAHAM KDirector M Exercise deriv2021-02-102021-02-2625,000— $00SEC↗
Hasnain FaheemDirector M Exercise deriv2021-02-102021-02-2625,000— $00SEC↗
BRADBURY DANIELDirector M Exercise deriv2021-02-102021-02-2625,000— $00SEC↗
Sharp ShaliniDirector M Exercise deriv2021-02-102021-02-2625,000— $00SEC↗
Hung DavidPresident and CEO A Award2021-02-102021-02-122,000,000$10.00 $20.00M58,645,012SEC↗
Hung DavidPresident and CEO A Award2021-02-102021-02-1256,645,012— $056,645,012SEC↗
Omega Fund V GP Manager, Ltd.10% Owner A Award2021-02-102021-02-12500,000$10.00 $5.00M28,212,373SEC↗
Omega Fund V GP Manager, Ltd.10% Owner C Conversion2021-02-102021-02-128,130,097— $027,712,373SEC↗
EcoR1 Capital, LLC10% Owner A Award2021-02-102021-02-122,365,511— $06,584,246SEC↗
EcoR1 Capital, LLC10% Owner A Award2021-02-102021-02-12387,265$10.00 $3.87M781,265SEC↗
EcoR1 Capital, LLC10% Owner A Award2021-02-102021-02-122,112,735$10.00 $21.13M4,218,735SEC↗
EcoR1 Capital, LLC10% Owner A Award2021-02-102021-02-122,200,627— $02,200,627SEC↗
EcoR1 Capital, LLC10% Owner A Award2021-02-102021-02-122,106,000— $02,106,000SEC↗
EcoR1 Capital, LLC10% Owner C Conversion2021-02-102021-02-122,775,000— $03,165,000SEC↗
EcoR1 Capital, LLC10% Owner A Award2021-02-102021-02-12515,879— $01,297,144SEC↗
EcoR1 Capital, LLC10% Owner A Award2021-02-102021-02-12394,000— $0394,000SEC↗
COOPER GRAHAM KDirector M Exercise2021-02-102021-02-2625,000— $025,000SEC↗
Hasnain FaheemDirector A Award2021-02-102021-02-2630,000$10.00 $300.0K55,000SEC↗
Hasnain FaheemDirector M Exercise2021-02-102021-02-2625,000— $025,000SEC↗
BRADBURY DANIELDirector M Exercise2021-02-102021-02-2625,000— $025,000SEC↗
Sharp ShaliniDirector M Exercise2021-02-102021-02-2625,000— $025,000SEC↗
Sharp ShaliniDirector A Award2021-02-102021-02-2610,000$10.00 $100.0K35,000SEC↗
VERNON W ANTHONYDirector A Award2020-02-102021-02-12254,100— $0254,100SEC↗
VERNON W ANTHONYDirector A Award2020-02-102021-02-1250,000$10.00 $500.0K304,100SEC↗